Nortropane alkaloids as pharmacological chaperones in the rescue of equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation, endoplasmic reticulum stress mitigation and insulin resistance alleviation

Abstract Objectives Equine metabolic syndrome (EMS) refers to a cluster of associated abnormalities and metabolic disorders, including insulin resistance and adiposity. The numerous biological properties of mesenchymal stem cells (MSCs), including self-renewal and multipotency, have been the subject...

Full description

Bibliographic Details
Main Authors: Lynda Bourebaba, Fatiha Bedjou, Michael Röcken, Krzysztof Marycz
Format: Article
Language:English
Published: BMC 2019-06-01
Series:Stem Cell Research & Therapy
Subjects:
Online Access:http://link.springer.com/article/10.1186/s13287-019-1292-z
_version_ 1818508479334187008
author Lynda Bourebaba
Fatiha Bedjou
Michael Röcken
Krzysztof Marycz
author_facet Lynda Bourebaba
Fatiha Bedjou
Michael Röcken
Krzysztof Marycz
author_sort Lynda Bourebaba
collection DOAJ
description Abstract Objectives Equine metabolic syndrome (EMS) refers to a cluster of associated abnormalities and metabolic disorders, including insulin resistance and adiposity. The numerous biological properties of mesenchymal stem cells (MSCs), including self-renewal and multipotency, have been the subject of many in-depth studies, for the management of EMS; however, it has been shown that this cell type may be affected by the condition, impairing thus seriously their therapeutic potential. Therefore, an attempt to rescue EMS adipose-derived stem cells (ASCs) with calystegines (polyhydroxylated alkaloids) that are endowed with strong antioxidant and antidiabetic abilities was performed. Methods ASCs isolated from EMS horses were subsequently treated with various concentrations of total calystegines. Different parameters were then assessed using flow cytometry, confocal as well as SE microscopy, and RT-qPCR. Results Our results clearly demonstrated that calystegines could improve EqASC viability and proliferation and significantly reduce apoptosis, via improvement of mitochondrial potentiation and functionality, regulation of pro- and anti-apoptotic pathways, and suppression of ER stress. Furthermore, nortropanes positively upregulated GLUT4 and IRS transcripts, indicating a possible sensitizing or mimetic effect to insulin. Most interesting finding in this investigation lies in the modulatory effect of autophagy, a process that allows the maintenance of cellular homeostasis; calystegines acted as pharmacological chaperones to promote cell survival. Conclusion Obtained data open new perspectives in the development of new drugs, which may improve the metabolic dynamics of cells challenged by MS.
first_indexed 2024-12-10T22:32:26Z
format Article
id doaj.art-6dd979be4ef7437fb94bd958ad53ad62
institution Directory Open Access Journal
issn 1757-6512
language English
last_indexed 2024-12-10T22:32:26Z
publishDate 2019-06-01
publisher BMC
record_format Article
series Stem Cell Research & Therapy
spelling doaj.art-6dd979be4ef7437fb94bd958ad53ad622022-12-22T01:31:02ZengBMCStem Cell Research & Therapy1757-65122019-06-0110112010.1186/s13287-019-1292-zNortropane alkaloids as pharmacological chaperones in the rescue of equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation, endoplasmic reticulum stress mitigation and insulin resistance alleviationLynda Bourebaba0Fatiha Bedjou1Michael Röcken2Krzysztof Marycz3Department of Experimental Biology, Faculty of Biology and Animal Science, Wrocław University of Environmental and Life SciencesLaboratoire de Biotechnologies végétales et d’Ethnobotanique, Faculté des Sciences de la Nature et de la Vie, Université de BejaiaFaculty of Veterinary Medicine, Equine Clinic - Equine Surgery, Justus-Liebig-UniversityDepartment of Experimental Biology, Faculty of Biology and Animal Science, Wrocław University of Environmental and Life SciencesAbstract Objectives Equine metabolic syndrome (EMS) refers to a cluster of associated abnormalities and metabolic disorders, including insulin resistance and adiposity. The numerous biological properties of mesenchymal stem cells (MSCs), including self-renewal and multipotency, have been the subject of many in-depth studies, for the management of EMS; however, it has been shown that this cell type may be affected by the condition, impairing thus seriously their therapeutic potential. Therefore, an attempt to rescue EMS adipose-derived stem cells (ASCs) with calystegines (polyhydroxylated alkaloids) that are endowed with strong antioxidant and antidiabetic abilities was performed. Methods ASCs isolated from EMS horses were subsequently treated with various concentrations of total calystegines. Different parameters were then assessed using flow cytometry, confocal as well as SE microscopy, and RT-qPCR. Results Our results clearly demonstrated that calystegines could improve EqASC viability and proliferation and significantly reduce apoptosis, via improvement of mitochondrial potentiation and functionality, regulation of pro- and anti-apoptotic pathways, and suppression of ER stress. Furthermore, nortropanes positively upregulated GLUT4 and IRS transcripts, indicating a possible sensitizing or mimetic effect to insulin. Most interesting finding in this investigation lies in the modulatory effect of autophagy, a process that allows the maintenance of cellular homeostasis; calystegines acted as pharmacological chaperones to promote cell survival. Conclusion Obtained data open new perspectives in the development of new drugs, which may improve the metabolic dynamics of cells challenged by MS.http://link.springer.com/article/10.1186/s13287-019-1292-zEMSASCsHyoscyamus albusCalysteginesIminosugarsInsulin resistance
spellingShingle Lynda Bourebaba
Fatiha Bedjou
Michael Röcken
Krzysztof Marycz
Nortropane alkaloids as pharmacological chaperones in the rescue of equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation, endoplasmic reticulum stress mitigation and insulin resistance alleviation
Stem Cell Research & Therapy
EMS
ASCs
Hyoscyamus albus
Calystegines
Iminosugars
Insulin resistance
title Nortropane alkaloids as pharmacological chaperones in the rescue of equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation, endoplasmic reticulum stress mitigation and insulin resistance alleviation
title_full Nortropane alkaloids as pharmacological chaperones in the rescue of equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation, endoplasmic reticulum stress mitigation and insulin resistance alleviation
title_fullStr Nortropane alkaloids as pharmacological chaperones in the rescue of equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation, endoplasmic reticulum stress mitigation and insulin resistance alleviation
title_full_unstemmed Nortropane alkaloids as pharmacological chaperones in the rescue of equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation, endoplasmic reticulum stress mitigation and insulin resistance alleviation
title_short Nortropane alkaloids as pharmacological chaperones in the rescue of equine adipose-derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation, endoplasmic reticulum stress mitigation and insulin resistance alleviation
title_sort nortropane alkaloids as pharmacological chaperones in the rescue of equine adipose derived mesenchymal stromal stem cells affected by metabolic syndrome through mitochondrial potentiation endoplasmic reticulum stress mitigation and insulin resistance alleviation
topic EMS
ASCs
Hyoscyamus albus
Calystegines
Iminosugars
Insulin resistance
url http://link.springer.com/article/10.1186/s13287-019-1292-z
work_keys_str_mv AT lyndabourebaba nortropanealkaloidsaspharmacologicalchaperonesintherescueofequineadiposederivedmesenchymalstromalstemcellsaffectedbymetabolicsyndromethroughmitochondrialpotentiationendoplasmicreticulumstressmitigationandinsulinresistancealleviation
AT fatihabedjou nortropanealkaloidsaspharmacologicalchaperonesintherescueofequineadiposederivedmesenchymalstromalstemcellsaffectedbymetabolicsyndromethroughmitochondrialpotentiationendoplasmicreticulumstressmitigationandinsulinresistancealleviation
AT michaelrocken nortropanealkaloidsaspharmacologicalchaperonesintherescueofequineadiposederivedmesenchymalstromalstemcellsaffectedbymetabolicsyndromethroughmitochondrialpotentiationendoplasmicreticulumstressmitigationandinsulinresistancealleviation
AT krzysztofmarycz nortropanealkaloidsaspharmacologicalchaperonesintherescueofequineadiposederivedmesenchymalstromalstemcellsaffectedbymetabolicsyndromethroughmitochondrialpotentiationendoplasmicreticulumstressmitigationandinsulinresistancealleviation